testosterone

• PHASE2COMPLETED
  Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide ResistanceSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT02286921
• PHASE3COMPLETED
  Assessment of Long Term Treatment With Testosterone Undecanoate in Males With HypogonadismBayer · NCT00220298
• WITHDRAWN
  Effect of Lap-Band Induced Weight Loss on Serum PSA LevelsMaimonides Medical Center · NCT00562341
• PHASE4COMPLETED
  A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With HypogonadismAbbVie · NCT04274894
• PHASE2COMPLETED
  Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot FlushesSolvay Pharmaceuticals · NCT00160342
• PHASE4COMPLETED
  A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate CancerSan Bernardino Urological Associates Medical Group Inc · NCT00220194

via ClinicalTrials.gov